NUCALA® Mepolizumab 100 mg Injection

Name: Interleukin-5 (IL-5)
Brand: NUCALA®

NUCALA, SDV 100MG

McKesson #

1184533

Manufacturer #

00173088101

Brand

NUCALA®

Manufacturer

Glaxo Specialty (Medical Benefit)

Country of Origin

Unknown

Application

Interleukin-5 (IL-5)

Buy American Act (BAA) Compliant

Container Type

Single-Dose Vial

Dosage Form

Injection

Generic Drug Name

Mepolizumab

NDC Number

00173088101

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Storage Requirements

Requires Refrigeration

Strength

100 mg

Trade Agreement Act (TAA) Compliant

Type

Subcutaneous

UNSPSC Code

51201806

NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: Add-on maintenance treatment of patients with severe asthma aged 6 years and older, and with an eosinophilic phenotype.
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
NUCALA is an interleukin-5 (IL-5) antagonist monoclonal antibody (IgG1 kappa) indicated for: The treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for ≥6 months without an identifiable non hematologic secondary cause.
Requires Refrigeration